Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Novo Nordisk said on Wednesday it is aware of 10 deaths and 100 hospitalizations resulting from people taking compounded ...

Weight loss can be a challenge, even for those who eat healthily ... The FDA advises getting semaglutide with a prescription ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

While plenty of people rave about the weight loss results you can get from drugs like Ozempic, there’s also been a ton of ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...

Semaglutide compounders could be next: Novo Nordisk has asked the FDA to bar compounding pharmacies from making compounds of ...

Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...